Interaction between β2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis
- 1 May 1997
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 51 (5), 1514-1519
- https://doi.org/10.1038/ki.1997.208
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Is β2-microglobulin a mediator of bone disease?Kidney International, 1995
- Demonstration of plasma proteinase inhibitors in β2-microglobulin amyloid depositsKidney International, 1992
- Deposition and Removal of Cutaneous Beta2-MicroglobulinAmerican Journal of Nephrology, 1992
- Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-β2-microglobulinKidney International, 1990
- Systemic Involvement of Dialysis-AmyloidosisAmerican Journal of Nephrology, 1990
- Beta-2-Microglobulin–Associated Amyloidosis in Chronic Hemodialysis Patients with Carpal Tunnel SyndromeMedicine, 1989
- Collagen-Binding Affinity of Beta-2-Microglobulin, a Preprotein of Hemodialysis-Associated AmyloidosisNephron, 1989
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Serum Levels of β2-Microglobulin as a New Form of Amyloid Protein in Patients Undergoing Long-Term HemodialysisNew England Journal of Medicine, 1986
- Beta 2-microglobulin and its binding activity in serum from patients with SLE.Annals Of The Rheumatic Diseases, 1984